Patents by Inventor Ikeotunye Royal Chinyere

Ikeotunye Royal Chinyere has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Cardiac electrophysiologic mapping and stimulation
    Patent number: 10856938
    Abstract: Systems are provided for assessing the likelihood that a sample of cardiac tissue will spontaneously exhibit disordered electrical activity. These systems induce ventricular tachycardia or other disordered electrical activity in a sample of human and/or animal cardiac tissue either in vivo or in vitro. This system can be used to assess the ability of various pharmaceuticals, genetic modifications, electrical pacing, surgical ablation, or other therapeutic interventions to prevent or halt such disordered electrical activity. This system detects electrical activity from a plurality of points on the surface of the sample of cardiac tissue and generates one or more maps of monophasic action potential amplitude, monophasic action potential duration, local field amplitude, or other electrophysiological parameters of the cardiac tissue.
    Type: Grant
    Filed: July 5, 2018
    Date of Patent: December 8, 2020
    Assignee: THE ARIZONA BOARD OF REGENTS ON BEHAFT OF THE UNIVERSITY OF ARIZONA
    Inventors: Ikeotunye Royal Chinyere, Jen Watson Koevary, Jordan Lancaster, Steven Goldman, Russell Witte, Kyle Weigand
  • Cardiac Electrophysiologic Mapping And Stimulation
    Publication number: 20190008584
    Abstract: Systems are provided for assessing the likelihood that a sample of cardiac tissue will spontaneously exhibit disordered electrical activity. These systems induce ventricular tachycardia or other disordered electrical activity in a sample of human and/or animal cardiac tissue either in vivo or in vitro. This system can be used to assess the ability of various pharmaceuticals, genetic modifications, electrical pacing, surgical ablation, or other therapeutic interventions to prevent or halt such disordered electrical activity. This system detects electrical activity from a plurality of points on the surface of the sample of cardiac tissue and generates one or more maps of monophasic action potential amplitude, monophasic action potential duration, local field amplitude, or other electrophysiological parameters of the cardiac tissue.
    Type: Application
    Filed: July 5, 2018
    Publication date: January 10, 2019
    Applicant: THE ARIZONA BOARD OF REGENTS ON BEHALF OF THE UNIV ERSITY OF ARIZONA
    Inventors: Ikeotunye Royal Chinyere, Jen Watson Koevary, Jordan Lancaster, Steven Goldman, Russell Witte, Kyle Weigand